Inventor · disambiguated record
Jin-Long Chen
Also filed as: CHEN JIN-LONG · CHEN Jin
23 granted patents·19 pending applications·427 citations·filing 1995–2022
96Inventor score
Top patents by PatentIndex Score
42 records- 0197US6653332B2Combination therapeutic compositions and method of useTULARIK INC·Filed 2001·Granted Nov 25, 2003·110 cites·25 claims
- 0294US6200995B1PPAR-γ modulatorsTULARIK INC·Filed 1999·Granted Mar 13, 2001·143 cites·58 claims
- 0392US11434491B2Compositions and methods for gene editingUNIV CALIFORNIA·Filed 2020·Granted Sep 6, 2022·7 cites·41 claims
- 0490US6620827B2PPARγ modulatorsTULARIK INC·Filed 2000·Granted Sep 16, 2003·36 cites·33 claims
- 0589US7939551B2Combination therapeutic compositionsAMGEN INC·Filed 2005·Granted May 10, 2011·12 cites·26 claims
- 0674US7056685B1Receptor ligands and methods of modulating receptorsAMGEN INC·Filed 2003·Granted Jun 6, 2006·9 cites·5 claims
- 0771US2023124253A1Compositions and Methods for Gene EditingUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0870US5698389ATranscriptional promoter of the murine obesity geneTULARIK INC·Filed 1995·Granted Dec 16, 1997·36 cites·7 claims
- 0968US2023103909A1Compositions and methods for gene editingUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1066US7358267B2Bis-aryl thiazole derivativesAMGEN INC·Filed 2002·Granted Apr 15, 2008·3 cites·21 claims
- 1162US2004259918A1Combination therapeutic compositions and method of useTULARIK INC·Filed 2003·Application pending·0 cites
- 1262US2009226436A1Novel receptorsAMGEN SF LLC·Filed 2009·Application pending·0 cites
- 1362US2008113449A1Novel receptorsTIAN HUI·Filed 2008·Application pending·0 cites
- 1461US5780258ADrug screens for regulators of the expression of the obese geneTULARIK INC·Filed 1996·Granted Jul 14, 1998·14 cites·6 claims
- 1559US6248561B1UCP3 genesTULARIK INC·Filed 2000·Granted Jun 19, 2001·2 cites·33 claims
- 1657US7189524B1Receptor ligands and methods of modulating receptorsAMGEN INC·Filed 2003·Granted Mar 13, 2007·3 cites·4 claims
- 1757US5807740ARegulators of UCP2 gene expressionTULARIK INC·Filed 1997·Granted Sep 15, 1998·10 cites·15 claims
- 1857US2007141644A1Novel ReceptorsTIAN HUI·Filed 2007·Application pending·0 cites
- 1956US2003082585A1Novel receptorsTULARIK·Filed 2002·Application pending·0 cites
- 2055US7105313B2Cell-based drug screens for regulators of gene expressionAMGEN INC·Filed 2003·Granted Sep 12, 2006·1 cites·21 claims
- 2154US6566089B1Cell-based drug screens for regulators of gene expressionTULARIK INC·Filed 1997·Granted May 20, 2003·9 cites·13 claims
- 2254US2024309345A1Compositions and methods for gene editingUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2353US2007207497A1Receptor ligands and methods of modulating receptorsAMGEN INC·Filed 2006·Application pending·0 cites
- 2452US2006264481A1Therapeutic modulation of PPARgamma activityAMGEN INC·Filed 2006·Application pending·0 cites
- 2551US5849581ARegulators of UCP3 gene expressionTULARIK INC·Filed 1997·Granted Dec 15, 1998·10 cites·19 claims
- 2651US2006223109A1G protein-coupled receptorsAMGEN INC·Filed 2006·Application pending·0 cites
- 2750US2003027252A1Novel receptorsTULARIK INC·Filed 2001·Application pending·0 cites
- 2849US2005182245A1Novel receptorsTULARIK INC·Filed 2005·Application pending·0 cites
- 2949US2005250820A1Therapeutic modulation of PPARgamma activityAMGEN INC·Filed 2005·Application pending·0 cites
- 3047US2005170397A1Novel receptorsTULARIK INC·Filed 2005·Application pending·0 cites
- 3146US5849514AMethod of identifying agents that modulate UCP2 promoter activityTULARIK INC·Filed 1998·Granted Dec 15, 1998·5 cites·23 claims
- 3246US2002127600A1Human uncoupling protein-2 (hCP2): compositions and methods of useFiled 2001·Application pending·0 cites
- 3345US2003045685A1Novel receptorsTULARIK INC·Filed 2002·Application pending·0 cites
- 3443US6432654B1Drug screens for regulators of the expression of the obese geneTULARIK INC·Filed 1998·Granted Aug 13, 2002·4 cites·5 claims
- 3541US6555326B1Nuclear hormone receptor fluorescence polarization assayTULARIK INC·Filed 1997·Granted Apr 29, 2003·8 cites·18 claims
- 3641US2003083245A1Novel receptorsTULARIK INC·Filed 2001·Application pending·0 cites
- 3735US5952469AMurine UCP3 polypeptidesTULARIK INC·Filed 1998·Granted Sep 14, 1999·1 cites·3 claims
- 3833US7101681B1Nuclear hormone receptor drug screensAMGEN INC·Filed 1998·Granted Sep 5, 2006·3 cites·29 claims
- 3931US6025469AMurine UCP3 polypeptidesTULARIK INC·Filed 1999·Granted Feb 15, 2000·0 cites·15 claims
- 4031US5976808AAssays for identifying agents which affect regulators of UCP3 gene expressionTULARIK INC·Filed 1998·Granted Nov 2, 1999·0 cites·16 claims
- 4131US5846779ANucleic acids encoding murine UCP3 genesTULARIK INC·Filed 1997·Granted Dec 8, 1998·1 cites·20 claims
- 4230US2003170606A1High-throughput screening assays for modulators of mitochondrial membrane potentialFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jin-Long Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →